Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
BIOMARKER:
Chr t(4;14)
Associations
(12)
News
Trials
B | Sensitive
C2 | Sensitive
C3 | Sensitive
D | Sensitive
B | Resistant
C2 | Resistant
C3 | Resistant
D | Resistant
Show legend
Include preclinical:
Drug categories
CD Protein Inhibitors
Immune Checkpoint Inhibitors
Immunotherapy
Interleukins
Proteasome Inhibitors
Tyrosine Kinase Inhibitors
Epigenetics
Cancel
Multiple Myeloma
Proteasome inhibitor + Immunomodulator
C3
Chr t(4;14)
|
Multiple Myeloma
|
Proteasome inhibitor + Immunomodulator
DVD
B
Chr t(4;14)
|
Multiple Myeloma
|
DVD
Isa-KRd
C2
Chr t(4;14)
|
Multiple Myeloma
|
Isa-KRd
lenalidomide + isatuximab-irfc
B
Chr t(4;14)
|
Multiple Myeloma
|
lenalidomide + isatuximab-irfc
elranatamab-bcmm
C3
Chr t(4;14)
|
Multiple Myeloma
|
elranatamab-bcmm
lenalidomide
C3
Chr t(4;14)
|
Multiple Myeloma
|
lenalidomide
lenalidomide + ixazomib
C3
Chr t(4;14)
|
Multiple Myeloma
|
lenalidomide + ixazomib
daratumumab
B
Chr t(4;14)
|
Multiple Myeloma
|
daratumumab
lenalidomide + elotuzumab
C3
Chr t(4;14)
|
Multiple Myeloma
|
lenalidomide + elotuzumab
PFI-3
D
Chr t(4;14)
|
Multiple Myeloma
|
PFI-3
bortezomib
C3
Chr t(4;14)
|
Multiple Myeloma
|
bortezomib
midostaurin
D
Chr t(4;14)
|
Multiple Myeloma
|
midostaurin
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
